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Background: Not enough is known about the prevalence of overweight and obesity in rural China in the current
decade. We aim to update our knowledge of the prevalence of obesity and its associated risk factors and comorbidities
in a large population sample in rural Northeast China.
Methods: A population-based survey of 11,579 participants aged 35 years and older was conducted in rural areas of
Liaoning Province during 2012–2013. Anthropometric measurements, information on health-related variables and blood
biochemical indexes were collected by well-trained personnel.
Results: The prevalence of general obesity and overweight was found to be 7.8% and 37.2%, respectively. The overall
prevalence of abdominal obesity was 15.1%. Female gender, ethnic minority, middle-school education and a family
income of 5,000–20,000 CNY per year were found to be risk factors for general obesity, while older age, female
gender, ethnic minority and longer sleep duration (>8 h/d) increased the risk of abdominal obesity, after adjusting for
confounders. Overweight and obese participants had significantly higher risks to develop prehypertension, hypertension,
high LDL-C and low HDL-C compared with normal weight participants, while abdominal obesity was associated with
increased risks of diabetes and high TG after adjusted for multiple factors. Compared with participants with a normal BMI
and no abdominal obesity, the participants classified as abdominally obese and normal BMI; as abdominally obese and
overweight; and abdominally obese and generally obese each had a progressive increase in the odds of hypertension
(OR: 1.961, 95% CI: 1.154 to 3.331, OR: 2.744, 95% CI: 2.126 to 3.541, and OR: 8.990, 95% CI: 5.858 to 13.795, respectively)
and high TG (OR: 3.165, 95% CI: 2.183 to 4.588, OR: 3.980, 95% CI: 3.332 to 4.755, and OR: 4.340, 95% CI: 3.574
to 5.271, respectively).
Conclusions: The prevalence of obesity in rural Northeast China exhibited a remarkably increasing upwards trend.
General and abdominal obesity were associated with different subtypes of cardiometabolic comorbidities, the combined
effects of which on the comorbidities dramatically increased.
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The prevalence of overweight and obesity has been increas-
ing rapidly all over the world [1,2], posing a major public
health burden worldwide. In developing countries, rates of
obesity have tripled in the past 20 years [3]. Aside from
being a potentially modifiable cardiovascular disease (CVD)
risk factor on its own, this non-communicable disease has
propelled an upsurge in other cardiometabolic comorbidi-
ties, including hypertension, dyslipidaemia, Type 2 diabetes
and metabolic syndrome [3,4].
The frequently-used anthropometric measurements of
adiposity are body mass index (BMI) and waist circum-
ference (WC). Abdominal fat deposition measured by WC
has been suggested as a better indicator of obesity in rela-
tion to CVDs than BMI [5,6]. Because BMI reflects a com-
bination of both fat mass and lean mass and WC reflects
a measure of central fat distribution, the combination of
these two indexes might be a more powerful predictor for
health risks. Incorporating evaluation of WC in addition to
BMI in clinical practice was advocated by many previous
studies [7,8]. However, there have been limited studies clari-
fying the associations between these two parameters and
cardiometabolic comorbidities, such as hypertension, dia-
betes and dyslipidaemia, in the rural Chinese population.
As in other developing countries, overweight and obesity
have become an important public health problem in China.
In China in 2000–2001 the prevalence of overweight
reached 26.9% in men and 31.1% in women [9]. Our
previous study conducted during 2004–2005 found that in
rural Northeast China the overall prevalence of overweight
was 18.6% [10]. Rural China is experiencing both a rapid
increase in economic progress and an epidemiologic tran-
sition. The prevalence of overweight and obesity in rural
areas after the year 2010 is unknown. The Northeast area
has its own climate, geography, history and lifestyles that
differ from those of other regions of China. We hypothe-
sized that huge changes may have taken place in the
prevalence, risk factors and cardiometabolic comorbidities
of obesity in rural Northeast China during this 10-year
period. Therefore, we undertook the present study to
update our knowledge of the prevalence of general and
abdominal obesity, as well as their risk factors, in rural
China; and to evaluate the independent and the combined
effects of general and abdominal obesity on different co-




Liaoning Province is located in Northeast China with a
population of more than 40 million. From January 2012 to
August 2013, a large scale epidemiological study was con-
ducted to evaluate the prevalence, incidence and natural
history of cardiovascular risk factors in rural areas ofLiaoning Province, which has around 40% of the total
population residing in more than 20 counties. We used
a random representative sample of the general rural popu-
lation aged ≥35 years. The study adopted a multi-stage,
stratified and random cluster-sampling design. In the first
stage, 3 counties (Dawa, Zhangwu, and Liaoyang County)
were selected from the Eastern, Southern, and Northern
regions of Liaoning province. In the second stage, 1 town
was randomly selected from each county (a total of 3
towns). In the third stage, 8–10 rural villages from each
town were randomly selected, yielding a total of 26 rural
villages included in the study. All eligible permanent resi-
dents aged ≥35 years from each village were invited to en-
roll in the study (a total of 14,016 participants). Of those,
11,956 participants with a mean ± standard value (SD) of
53.9 ± 10.6 years agreed and completed the study, yield-
ing an overall response rate of 85.3%. Participants with
pregnancy, malignant tumor and mental disorder were
excluded from the study. This study was approved by the
Ethics Committee of China Medical University (Shenyang,
China). All procedures were performed in accordance with
the institution’s ethical standards. Written consent was ob-
tained from all participants after they had been informed
of the objectives, benefits, medical particulars and confi-
dentiality agreements for personal information. If the
participants were illiterate, we obtained written informed
consent from their proxies. In this report, we used data of
baseline and only participants with a complete set of data
regarding the variables analyzed in the study was included,
making a final sample size of 11,579 (5,361 men and 6,218
women).
Data collection and measurements
Data collection was performed in the local healthcare cen-
ters in participants’ residential area. Data were collected
by cardiologists and trained nurses using a standard ques-
tionnaire delivered by face-to-face interview. Before the
survey was performed, all eligible investigators were in-
vited to attend organized training. The training contents
included the purpose of this study, how to administer the
questionnaire, the standard method of measurement, the
importance of standardization, and the study procedures.
A strict evaluation was done after this training, and only
those who scored perfectly on the test could become in-
vestigators. During data collection, our inspectors received
further instructions and support.
Data on demographic characteristics, lifestyle risk factors,
dietary habits, family income, family history of cardiovas-
cular disease, medical history of hypertension, evaluation
of psychological status, and quality of life were obtained by
interview using a standardized questionnaire. A central
steering committee with a subcommittee was estab-
lished for the purposes of quality control. Educational
level was divided into primary school or below, middle
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classified as ≤5,000, 5,000–20,000 and >20,000 CNY/year.
Smoking and drinking status were classified by the par-
ticipants’ self-report as current versus nonsmokers. Self-
reported sleep duration (including nocturnal and nap
duration) was obtained from the questionnaire. The re-
sponses were categorized into four groups: ≤7, 7–8, 8–9,
and >9 h/d.
All anthropometric measurements were made by two
trained cardiologists. According to the American Heart As-
sociation protocol, blood pressure was measured 3 times at
2-min intervals after at least 5 min of rest using a standard-
ized automatic electronic sphygmomanometer (HEM-907;
Omron, Tokyo, Japan), which had already been vali-
dated according to the British Hypertension Society
protocol [11]. The participants were advised to avoid
caffeinated beverages and exercise for at least 30 min
before the measurement. During the measurement, the
participants were seated with the arm supported at the
level of the heart. The mean of 3 blood pressure (BP) mea-
surements was calculated and used in all analyses.
Weight was measured with the participants wearing
lightweight clothing on a calibrated scale and height was
measured without shoes using a portable stadiometer.
Weight and height were measured to the nearest 0.1 kg
and 0.1 cm respectively. WC was measured at the umbil-
icus using a non-elastic tape (to the nearest 0.1 cm), with
the participants standing at the end of normal expiration.
BMI was calculated as weight in kilograms divided by the
square of the height in meters.
Fasting blood samples were collected in the morning after
at least 12 h of fasting for all participants. Blood samples
were obtained from an antecubital vein into Vacutainer
tubes containing EDTA. Serum was subsequently isolated
from the whole blood, and all serum samples were frozen
at −20°C for testing at a central certified laboratory. Fasting
plasma glucose (FPG), total cholesterol (TC), low-density
lipoprotein cholesterol (LDL-C), high-density lipopro-
tein cholesterol (HDL-C), triglyceride (TG) and other
routine blood biochemical indexes were analyzed enzy-
matically on an Olympus AU640 auto analyzer (Olympus,
Kobe, Japan). All analytes were measured in an auto
analyzer (Bayer RA-XT, Tarrytown, NY, USA) using kits
by the same company.
Definitions
According to the JNC-7 report [12], prehypertension was
defined as not being on antihypertensive medication and
having a systolic BP (SBP) of 120–139 mmHg or diastolic
BP (DBP) of 80–89 mmHg. Hypertension was defined as
SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or use of
antihypertensive medications. BMIs were categorized into
3 groups as normal (BMI < 25 kg/m2), overweight (25 ≤
BMI <30 kg/m2) and obesity (BMI ≥ 30 kg/m2), accordingto the World Health Organization (WHO) criteria [13].
Abdominal obesity was defined as WC ≥ 88 cm for females
and WC ≥ 102 cm for males [14]. Dyslipidemia was defined
according to the National Cholesterol Education Program-
Third Adult Treatment Panel (ATP III) criteria [15]. High
TC was defined as TC ≥ 6.21 mmol/L(240 mg/dL). Low
HDL-C was defined as HDL-C < 1.03 mmol/L (40 mg/dL).
High LDL-C was defined as LDL-C ≥ 4.16 mmol/L
(160 mg/dL). High TG was defined as ≥2.26 mmol/L
(200 mg/dL). Diabetes mellitus was diagnosed according
to the WHO criteria: FPG ≥ 7 mmol/L (126 mg/dL)
and/or being on treatment for diabetes [16].
Physical activity included occupational and leisure-time
physical activity. A detailed description of the methods
has been presented elsewhere [17]. Occupational and
leisure-time physical activity were merged and regrouped
into 3 categories: (1) low—subjects who reported light
levels of both occupational and leisure-time physical activ-
ity; (2) moderate—subjects who reported moderate or
high levels of either occupational or leisure-time physical
activity; and (3) high—subjects who reported a moderate
or high level of both occupational and leisure-time phys-
ical activity.
The dietary pattern was assessed using the subjects’ re-
call of foods eaten in the previous year. The questionnaire
included questions on the average consumption of sev-
eral food items per week. The reported consumption was
quantified approximately in terms of grams per week (vege-
table consumption: rarely = 3, <1,000 g = 2, 1,000–2,000
g = 1, ≥2,000 g = 0; meat consumption including red
meat, fish, and poultry: rarely = 0, <250 g = 1, 250-500 g =
2, ≥500 g = 3). A special diet score (vegetable consumption
score plus meat consumption score) was calculated for each
participant (range 0–6). Higher values of the diet score in-
dicated higher meat consumption and lower vegetable con-
sumption and greater adherence to a Westernized diet,
while lower values indicated adherence to the Chinese-diet.
Similar methods for calculating diet score could be found
in the ATTICA study [18].
Statistical analysis
Descriptive statistics were calculated for all the variables,
including continuous variables (reported as mean values
and SDs) and categorical variables (reported as numbers
and percentages). Differences among weight categories were
evaluated using Student’s t-test, ANOVA, non-parametric
test or the χ2-test as appropriate. Multivariate logistic re-
gression analyses were used to identify independent factors
and associated comorbidities of general obesity and abdom-
inal obesity with odds ratios (ORs) and corresponding 95%
confidence intervals (CIs) calculated. All the statistical ana-
lyses were performed using SPSS version 17.0 software, and
P values less than 0.05 were considered to be statistically
significant.
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Baseline characteristics of study population
Table 1 presents the baseline characteristics of included
participants according to BMI and WC categories. Older
participants were more likely to have normal weight and
to be abdominally obese. A higher proportion of either
general obesity or abdominal obesity was observed among
females. Ethnic difference was only observed in BMI cat-
egories. Participants with general or abdominal obesity
tended to have a more unfavorable metabolic profile (eg.
higher values of SBP, DBP, FPG, TC, TG and LDL-C,
all P < 0.05). In addition, current smokers or drinkersTable 1 Baseline characteristics of study population accordin
Variables BMI (kg/m2)
Normal weight Overweight Obesi
Age (year) 54.3 ± 10.9 53.5 ± 10.2 52.3 ±
Male gender 3010 (47.3) 1997 (46.3) 354 (
Ethnicity
Han 6069 (95.3) 4072 (94.5) 833 (
Othersa 300 (4.7) 239 (5.5) 66 (
Education
Primary school or below 3183 (50.0) 2162 (50.2) 422 (
Middle school 2612 (41.0) 1730 (40.1) 377 (
High school or above 574 (9.0) 419 (9.7) 100 (
Physical activity
Low 1814 (28.5) 1353 (31.4) 276 (
Moderate 4213 (66.1) 2700 (62.6) 570 (
High 342 (5.4) 258 (6.0) 53 (
Family income (CNY/year)
≤5000 871 (13.7) 484 (11.2) 87 (
5000-20000 3430 (53.9) 2371 (55.0) 509 (
>20000 2068 (32.5) 1456 (33.8) 303 (
Current smoking status 2525 (39.6) 1342 (31.1) 222 (
Current drinking status 1490 (23.4) 958 (22.2) 170 (
Diet score 2.3 ± 1.1 2.4 ± 1.1 2.3 ±
Sleep duration (h/d) 7.2 ± 1.7 7.3 ± 1.7 7.4 ±
SBP (mmHg) 137.7 ± 22.6 145.9 ± 23.4 150.8 ±
DBP (mmHg) 79.8 ± 11.3 84.4 ± 11.6 87.2 ±
BMI (kg/m2) 22.2 ± 1.9 27.1 ± 1.4 32.4 ±
WC (cm) 76.7 ± 7.1 87.6 ± 6.6 98.3 ±
TC (mmol/L) 5.1 ± 1.1 5.3 ± 1.1 5.4 ±
TG (mmol/L) 1.4 ± 1.3 1.9 ± 1.6 2.2 ±
LDL-C (mmol/L) 2.8 ± 0.8 3.1 ± 0.8 3.2 ±
HDL-C (mmol/L) 1.5 ± 0.4 1.3 ± 0.3 1.3 ±
FPG (mmol/L) 5.7 ± 1.5 6.1 ± 1.8 6.3 ±
Data are expressed as the mean ± SD or as n (%).
Abbreviations: BMI body mass index, WC waist circumference, CNY China Yuan (1CN
TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C
aIncluding some ethnic minorities in China, such as Mongol and Manchu.were more common in participants with normal BMI
and WC.
Prevalence of overweight, obesity and abdominal obesity
Table 2 presents the prevalence of overweight, general
obesity and abdominal obesity among the different groups.
Mean BMI and WC were 24.8 ± 3.7 kg/m2 and 82.4 ±
9.8 cm, respectively. The overall prevalence of general
obesity and overweight was 7.8% (6.6% for males and 8.8%
for females) and 37.2% (37.3% for males and 37.2% for fe-
males), respectively. The overall prevalence of abdominal
obesity was 15.1% (3.9% for males and 24.8% for females).g to weight categories
WC (cm)
ty P-value Non-obesity Abdominal obesity P-value
9.9 <0.001 53.6 ± 10.6 54.9 ± 10.1 <0.001
39.4) <0.001 5151 (52.4) 210 (12.0) <0.001
92.7) 9330 (94.9) 1644 (94.0)
7.3) 0.002 500 (5.1) 105 (6.0) 0.112
46.9) 4719 (48.0) 1048 (59.9)
41.9) 4147 (42.2) 572 (32.7)
11.1) 0.151 964 (9.8) 129 (7.4) <0.001
30.7) 2789 (28.4) 654 (37.4)
63.4) 6507 (66.2) 976 (55.8)
5.9) 0.006 534 (5.4) 119 (6.8) <0.001
9.7) 1213 (12.3) 229 (13.1)
56.6) 5319 (54.1) 991 (56.7)
33.7) <0.001 3298 (33.6) 529 (30.2) 0.025
24.7) <0.001 3765 (38.3) 324 (18.5) <0.001
18.9) 0.008 2480 (25.2) 138 (7.9) <0.001
1.1 <0.001 2.4 ± 1.1 2.2 ± 1.2 <0.001
1.6 <0.001 7.3 ± 1.7 7.2 ± 1.7 0.437
23.5 <0.001 140.4 ± 22.9 149.3 ± 25.1 <0.001
12.0 <0.001 81.5 ± 11.6 85.0 ± 12.0 <0.001
2.9 <0.001 24.0 ± 3.1 29.2 ± 3.4 <0.001
8.3 <0.001 80.1 ± 8.4 95.3 ± 7.0 <0.001
1.2 <0.001 5.2 ± 1.1 5.5 ± 1.2 <0.001
2.0 <0.001 1.5 ± 1.4 2.1 ± 1.6 <0.001
0.9 <0.001 2.9 ± 0.8 3.2 ± 0.9 <0.001
0.3 <0.001 1.4 ± 0.4 1.3 ± 0.3 <0.001
1.8 <0.001 5.8 ± 1.6 6.3 ± 2.0 <0.001
Y = 0.161 USD), SBP systolic blood pressure, DBP diastolic blood pressure,
high-density lipoprotein cholesterol, FPG fasting plasma glucose.
Table 2 Prevalence of overweight, obesity and adominal obesity in rural Chinese population by age and sex
Age (year) Sample size BMI (kg/m2) Overweight Obesity WC (cm) Abdominal obesity
Male
35-44 1219 25.4 ± 4.0 468 (38.4) 124 (10.2) 84.8 ± 10.2 71 (5.8)
45-54 1621 24.9 ± 3.3 648 (40.0) 108 (6.7) 84.0 ± 9.4 62 (3.8)
55-64 1636 24.4 ± 3.4 584 (35.7) 85 (5.2) 83.2 ± 9.5 52 (3.2)
≥65 885 24.0 ± 3.4 297 (33.6) 37 (4.2) 83.2 ± 10.0 25 (2.8)
All 5361 24.7 ± 3.5 1997 (37.3) 354 (6.6) 83.8 ± 9.8 210 (3.9)
Female
35-44 1533 24.8 ± 3.8 538 (35.1) 125 (8.2) 79.2 ± 9.1 256 (16.7)
45-54 1978 25.1 ± 3.6 783 (39.6) 190 (9.6) 81.4 ± 9.2 491 (24.8)
55-64 1848 25.0 ± 3.8 690 (37.3) 171 (9.3) 82.5 ± 10.0 537 (29.1)
≥65 859 24.2 ± 3.9 303 (35.3) 59 (6.9) 82.1 ± 10.8 255 (29.7)
All 6218 24.9 ± 3.8 2314 (37.2) 545 (8.8) 81.3 ± 9.7 1539 (24.8)
Data are expressed as the mean ± SD or as n (%).
Abbreviations: BMI body mass index, WC waist circumference.
Guo et al. BMC Public Health 2014, 14:1046 Page 5 of 9
http://www.biomedcentral.com/1471-2458/14/1046The distribution of obesity status differed among four age
categories.
Factors associated with obesity status
Table 3 presents the multivariable logistic regression ana-
lysis of risk factors related to general and abdominal obes-
ity. Increased age was associated with an increased risk of
abdominal obesity but a decreased risk of general obesity
(both P for trend <0.001). Compared with males, females
were at greater risk of developing both general obesity
(OR: 3.777, 95% CI: 2.958 to 4.822) and abdominal obesity
(OR: 7.297, 95% CI: 6.089 to 8.744). Ethnic minority was
associated with a higher risk of both types of obesity com-
pared to the ethnicity of Han (general obesity: OR: 1.469,
95% CI: 1.020 to 2.114; abdominal obesity: OR: 1.299, 95%
CI: 1.031 to 1.638). Current smokers were less likely to be
generally or abdominally obese. Moderate physical activity
was found to be a protective factor for abdominal obesity
(OR: 0.858, 95% CI: 0.762 to 0.966), while longer sleep du-
rations (>8 h/d) increased its risk. The OR of general obes-
ity was increased (P < 0.05) for those with a family income
of 5,000–20,000 CNY per year in comparison to those
with a lower family income (≤5,000 CNY per year).
Education at middle school had opposite effects on the
two obesity types.
Weight status and cardiometabolic comorbidities
Figure 1 presents associations between weight status and
cardiometabolic comorbidities. Overweight and obese
participants had significantly higher risks for prehyper-
tension, hypertension, high LDL-C and low HDL-C com-
pared with normal weight participants, while abdominal
obesity was associated with increased risks of diabetes and
high TG after adjustment for the potential contributions.
Table 4 presents combined effects of general and abdominalobesity on the cardiometabolic comorbidities. Participants
with both general and abdominal obesity had much higher
risks of all seven kinds of comorbidities. Compared with
participants with a normal BMI and no abdominal obesity,
the participants classified as abdominally obese and normal
BMI, as abdominally obese and overweight, and abdomin-
ally obese and generally obese, each had a progressive
increase in the odds of hypertension (OR: 1.961, 95% CI:
1.154 to 3.331, OR: 2.744, 95% CI: 2.126 to 3.541, and OR:
8.990, 95% CI: 5.858 to 13.795, respectively) and high TG
(OR: 3.165, 95% CI: 2.183 to 4.588, OR: 3.980, 95% CI:
3.332 to 4.755, and OR: 4.340, 95% CI: 3.574 to 5.271, re-
spectively). With the exception of high TC, the odds for all
the comorbidities were increased (P < 0.05) for those with
solely general obesity compared with those with a normal
BMI and no abdominal obesity.
Discussion
The present study aimed at characterizing the current
prevalence of overweight, obesity and abdominal obesity
in rural areas of Northeast China. We found an increased
prevalence of general obesity in both genders, and an espe-
cially high prevalence of abdominal obesity among females.
General and abdominal obesity had different risk profiles
and were associated with different comorbidities. The com-
bined effects of both obesity types on cardiometabolic co-
morbidities was much larger than either one alone.
As a consequence of rapid economic development and
industrialization, China has experienced rapidly escalating
rates of obesity. It is estimated that the combined preva-
lence of overweight and obesity (BMI ≥ 25 kg/m2) increased
by 49.5% between the years 1992 and 2002 [19]. During the
period 1993–2009, the combined prevalence increased by
97%, from 13.4% in 1993 to 26.4% in 2009 [20]. In the
present study, we found that the prevalence of general
Table 3 Multiple regression analyses of general and abdominal obesity and associated factors
Variables General obesity P-value
for trend
Abdominal obesity P-value
for trendOR (95% CI) P-value OR (95% CI) P-value
Age (year) <0.001 <0.001
35-44 1.000 (reference) 1.000 (reference)
45-54 0.76 (0.597-0.967) 0.026* 1.379 (1.182-1.610) <0.001*
55-64 0.503 (0.384-0.658) <0.001* 1.536 (1.301-1.814) <0.001*
≥65 0.338 (0.236-0.483) <0.001* 1.457 (1.187-1.788) <0.001*
Gender
Male 1.000 (reference) 1.000 (reference)
Female 3.777 (2.958-4.822) <0.001* 7.297 (6.089-8.744) <0.001*
Ethnicity
Han 1.000 (reference) 1.000 (reference)
Othersa 1.469 (1.020-2.114) 0.039* 1.299 (1.031-1.638) 0.027*
Education 0.023 0.014
Primary school or below 1.000 (reference) 1.000 (reference)
Middle school 1.249 (1.010-1.544) 0.04* 0.856 (0.754-0.972) 0.017*
High school or above 1.382 (0.995-1.918) 0.053 0.837 (0.675-1.038) 0.104
Physical activity 0.113 0.516
Low 1.000 (reference) 1.000 (reference)
Moderate 1.211 (0.980-1.496) 0.077 0.858 (0.762-0.966) 0.011*
High 1.130 (0.759-1.682) 0.548 1.150 (0.914-1.448) 0.234
Family income (CNY/year) 0.347 0.251
≤5000 1.000 (reference) 1.000 (reference)
5000-20000 1.438 (1.042-1.982) 0.027* 0.967 (0.815-1.148) 0.702
>20000 1.354 (0.960-1.910) 0.084 0.883 (0.731-1.067) 0.197
Current smoking status 0.678 (0.540-0.852) 0.001* 0.724 (0.627-0.836) <0.001*
Current drinking status 0.897 (0.680-1.182) 0.439 1.074 (0.861-1.339) 0.529
Sleep duration (h/d) 0.737 0.002
≤7 1.000 (reference) 1.000 (reference)
7-8 1.037 (0.835-1.289) 0.741 1.062 (0.934-1.208) 0.361
8-9 0.944 (0.717-1.243) 0.681 1.246 (1.058-1.467) 0.008*
>9 1.017 (0.727-1.422) 0.923 1.335 (1.089-1.635) 0.005*
Diet score (per 1 unit) 0.973 (0.896-1.057) 0.52 0.997 (0.950-1.047) 0.912
*P < 0.05 for the independent association between general obesity or abdominal obesity and each factor after adjusting for the remaining factors.
Abbreviations: OR odds ratio, 95% CI 95% confidence interval, CNY China Yuan (1CNY = 0.161 USD).
aIncluding some ethnic minorities in China, such as Mongol and Manchu.
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2.2% for females and 6.6% vs.1.2% for males) and two-
fold (37.2% vs. 22.1% for females and 37.3% vs.15.1% for
males), respectively, compared with 10 years ago [10].
Nearly half the population were generally obese or over-
weight, and the prevalence of abdominal obesity was ap-
proaching the rate in urban areas. This explosive growth
might be explained by the fact that in recent years the
rural population in Northeast China has experienced huge
changes in lifestyle and an increase in life expectancy. The
prevalence of general obesity and overweight we observedwas higher than those in rural populations of other prov-
inces in China [21] and other Asian countries, such as
Japan and Korea [22,23], using the same criteria. Also, we
found that the prevalence was even higher than that in
urban areas of the same province [24], challenging the
viewpoint that overweight and obesity are more common
in urban than in rural residents. The dramatic increase in
the prevalence of obesity in rural areas was also observed
in other countries [25,26]. Taken together, the present
study reinforces that the prevalence of overweight and
obesity in the rural population in Northeast China has
Figure 1 Associations between weight status and different cardiometabolic comorbidities. Results were adjusted for age, gender, ethnicity,
education, physical activity, family income, smoking status, drinking status, sleep duration, diet, blood pressure, fasting plasma glucose and lipid
status.
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should become a public health concern.
Consistent with previous studies [24,27,28], we found
that the risk of abdominal obesity increased with aging.
However, interestingly, although evidence existed of a posi-
tive relation between aging and general obesity [29,30], an
inverse association was observed in the present population.
This might be explained in part by the fact that aging
caused a loss of subcutaneous fat, decrease of lean mass
and accumulation of visceral fat [31-33], leading to a large
proportion of the population developing abdominal obesity
rather than general obesity. In developed countries, the
prevalence of obesity is similarly high in both males and fe-
males. However, in countries with a relatively low gross na-
tional product, the prevalence of obesity is 1.5 to 2 timesTable 4 Combined effects of general and abdominal obesity o
Abdominal
obesity + normal BMI
BMIAbdominal
obesity + overweigh
OR (95% CI)* P-value OR (95% CI)* P-v
Prehypertension 1.169 (0.672-2.033) 0.582 1.330 (1.026-1.724) 0.0
Hypertension 1.961 (1.154-3.331) 0.013 2.744 (2.126-3.541) <0
Diabetes 1.175(0.726-1.903) 0.511 1.879 (1.515-2.330) <0
High TC 1.666 (1.160-2.393) 0.006 1.353 (1.128-1.624) 0.0
Low HDL-C 2.388 (1.508-3.782) <0.001 2.021 (1.609-2.538) <0
High LDL-C 1.391 (0.830-2.332) 0.21 1.535 (1.196-1.971) 0.0
High TG 3.165 (2.183-4.588) <0.001 3.980 (3.332-4.755) <0
*Adjusted for age, gender, ethnicity, education, physical activity, family income, sm
plasma glucose and lipid statuswith participants with a normal BMI and no abdomi
95% CI 95% confidence interval, TC total cholesterol, TG triglyceride, LDL-C low-denhigher among females than among males [34]. In the
present study, we found an especially higher prevalence
of abdominal obesity among females, which was similar
to the findings of other studies [35,36]. For instance,
Janghorbani et al. have reported that the prevalence of
abdominal obesity in Iranian adults was found to be higher
in women (53.5%) than in men (12.5%) [36]. Compared to
males, we found that the risks for general obesity and
abdominal obesity were about four times and seven
times higher respectively in females. One possible ex-
planation for the difference might be that in rural areas
men engaged in more strenuous activity, and many women
are mainly housewives, with less activity to engage in.
However, the root causes for this gender-specific difference
warrant further study. Unlike the results from urban areasn different cardiometabolic comorbidities
t
Abdominal
obesity + general obesity
No abdominal
obesity + general obesity
alue P-valueOR (95% CI)* P-value OR (95% CI)* P-value
31 3.714 (2.406-5.734) <0.001 2.031 (1.146-3.597) 0.015
.001 8.990 (5.858-13.795) <0.001 4.956 (2.836-8.661) <0.001
.001 1.949 (1.534-2.476) <0.001 1.655 (1.113-2.459) 0.013
01 1.502 (1.221-1.847) <0.001 1.319 (0.914-1.904) 0.14
.001 3.010 (2.398-3.779) <0.001 4.772 (3.543-6.429) <0.001
01 2.343 (1.806-3.041) <0.001 1.853 (1.129-3.040) 0.015
.001 4.340 (3.574-5.271) <0.001 4.015 (2.988-5.395) <0.001
oking status, drinking status, sleep duration, diet, blood pressure, fasting
nal obesity as reference. Abbreviations: BMI body mass index, OR odds ratio,
sity lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol.
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had a lower risk of obesity than other Chinese ethnic
minorities. This might be attributed to genetic and
lifestyle-related differences.
In line with the results of previous studies [36-38], an
inverse association was observed between current smok-
ing status and both general and abdominal obesity in the
present study. This was further confirmed by the inverse
dose–response relationship between the number of ciga-
rettes smoked and overweight found by Xu et al. [39].
Smoking cessation might increase the risk of gaining
overall body weight and developing central obesity [39],
which should be taken into account when devising strat-
egies for the prevention of obesity. In addition, we found
that the effects of education level, physical activity, family
income and sleep duration on general obesity and abdom-
inal obesity were different. Further studies are expected to
confirm these results.
The separate effects of general obesity or abdominal
obesity on adverse cardiometabolic profile varied in a sub-
stantial number of epidemiologic studies, depending on
the different populations, the confounding factors consid-
ered and the scales for measurement of variables. Our
study found that general obesity was associated with a 2.1-
fold and 2.7-fold risk for prehypertension and hyperten-
sion respectively, while abdominal obesity was associated
with a 1.3-fold risk for diabetes. This could be explained
by the observation that WC better reflected visceral fat
and was closely associated with insulin resistance and
diabetes, whereas BMI better indicated body volume and
mass, which was associated with blood viscosity and blood
volume, and was closely related to blood pressure [40]. To
be noticed, in the present study some other endocrino-
logical diseases such as type 1 diabetes, Cushing’s disease
or hyperthyroidism that may cause body weight alteration
were not excluded, which might compromise the results
to some extent. We assumed that measuring WC could
provide additional meaningful information beyond that pro-
vided by BMI for accurately predicting obesity-associated
cardiometabolic comorbidities, which was supported by the
results of our combined analyses of the two types of obesity.
For instance, we found that the combination of general and
abdominal obesity was associated with a much greater risk
of hypertension compared with general obesity alone (ORs
of 8.99 vs. 2.69). A similar result was also observed in a re-
cent study based on the US National Health and Nutrition
Examination Survey (NHANES) 2007–2010 [41]. Unlike the
results from separate analysis, the risks of all the comorbidi-
ties, including prehypertension, hypertension, diabetes and
four subtypes of dyslipidemia, were increased when the ef-
fects of two types of excess weight were combined. Accord-
ing to the data from the China Health and Nutrition Survey
(CHNS), more than 65% of individuals with obesity would
be missed if BMI alone was measured [8]. Therefore, webelieve that efforts to promote the measurement of WC in
clinical practice are crucial.
The present study has several limitations. The major
one is its cross-sectional nature, which suggests that it
cannot provide sufficient evidence of causality. Second,
China is a vast country with diverse lifestyles. Our data
are not representative of the rural population through-
out the country and the findings cannot be extrapolated
to other provinces. In addition, although the researchers
had been trained according to a standardized protocol of
measurements, measurements at a single visit might lead
to incorrect values for the anthropometric indexes. Also,
the sample size of ethnic minorities was too small and the
conclusion should be carefully considered. Other limita-
tions include recall bias and the small sample sizes available
in some other subgroup analyses that reduce the statistical
power to detect significant associations.
Conclusions
In summary, our population-based study indicated a dra-
matically increased prevalence of overweight and obesity
in rural areas of Northeast China. General and abdominal
obesity exhibited different risk profiles and were related to
different adverse comorbidities. The large obese popula-
tion and the wide-ranging effects that excess body weight
has on health should be considered in the development of
rural areas. The combined effects of both obesity types on
cardiometabolic comorbidities were much greater than ei-
ther one alone, indicating the importance of the combined
use of both WC and BMI in clinical work.
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